All In Biotech

Drug Trial Radar · NCT05168566

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

A Multicenter, Open-label, Phase IIb Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC (Non-resistant Uncommon EGFR Mutations Only, Including L861Q, G719X, and/or S768I)

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

128

Planned (sponsor's estimate)

Start

Sep 1, 2022

Primary completion

Dec 2027

Study completion Dec 2028

Sponsor

Lead sponsor
Teligene USIndustry
Sponsor type
Industry
First posted
Dec 23, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2b, multicenter, open-label study to evaluate the safety and efficacy of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC (Non-resistant Uncommon EGFR Mutations Only, Including L861Q, G719X, and/or S768I)

Conditions

  • Non-small Cell Lung Cancer

Interventions

  • Sutetinib Maleate CapsuleDrug

    Study drug to be taken orally once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of Objective response rate (ORR)Time frame: 2 Years

Locations

31 sites in 3 countries. Site status is shown where the registry gives one.

  • OPN Healthcare, Inc.

    Glendale, California · Recruiting

  • Georgetown Lombardi Comprehensive Cancer Center

    Washington D.C., District of Columbia · Recruiting

  • University Cancer & Blood Center

    Athens, Georgia · Recruiting

  • Baptist Health

    Louisville, Kentucky · Withdrawn

  • University of Maryland Medical Center

    Baltimore, Maryland · Recruiting

  • FirstHealth Cancer Center

    Pinehurst, North Carolina · Recruiting

  • University of Texas MD Anderson Cancer Center

    Houston, Texas · Active not recruiting

  • Virginia Cancer Specialists

    Fairfax, Virginia · Recruiting

  • Macquarie University Hospital

    Sydney, New South Wales, Australia · Recruiting

  • Sunshine Coast Hospital and Health Service

    Birtinya, Queensland, Australia · Recruiting

  • St John of God Subiaco Hospital

    Subiaco, Western Australia, Australia · Recruiting

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, China · Active not recruiting

  • Cancer Hospital Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, China · Active not recruiting

  • Beijing Cancer Hospital

    Beijing, Beijing Municipality, China · Active not recruiting

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China · Active not recruiting

  • Beijing Chest Hospital

    Beijing, Beijing Municipality, China · Active not recruiting

  • The Affiliated Cancer Hospital of Chongqing University

    Chongqing, Chongqing Municipality, China · Active not recruiting

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China · Active not recruiting

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, China · Active not recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, China · Active not recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Active not recruiting

  • Wuhan Union Hospital of China

    Wuhan, Hubei, China · Active not recruiting

  • Hunan Cancer Hospital

    Changsha, Hunan, China · Active not recruiting

  • Jiangsu Province Hospital

    Nanjing, Jiangsu, China · Active not recruiting

  • Jilin Cancer Hospital

    Changchun, Jilin, China · Active not recruiting

  • The First Affiliated Hospital of China Medical University

    Shenyang, Liaoning, China · Active not recruiting

  • Linyi Cancer Hospital

    Linyi, Shandong, China · Active not recruiting

  • Shanghai Chest Hospital

    Shanghai, Shanghai Municipality, China · Active not recruiting

  • Shanghai Pulmonary Hospital

    Shanghai, Shanghai Municipality, China · Active not recruiting

  • Sichuan Cancer Hospital

    Chengdu, Sichuan, China · Active not recruiting

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, China · Active not recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.